GENZ results give pause

GENZ results give pause

Genzyme Corp. reported an improved quality of life with its Thyrogen recombinant thyroid stimulating hormone (TSH) as a scanning aid for detecting thyroid cancer. But GENZ is holding off on filing an NDA until meeting with the FDA next month. The glitch is that a few percent of patients did not have their recurrent disease show

Read the full 606 word article

How to gain access

Continue reading with a
two-week free trial.